Health Affairs March 6, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads.” Articles in this topic will offer timely analysis of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress.
The Trump Administration may make significant reforms to how Medicare covers new devices, drugs, and diagnostics. Most sweepingly, the new Administration could eliminate Medicare’s “coverage with evidence development” (CED) program, for which statutory authority has long been debated. Under CED, Medicare provides coverage for a new treatment or technology on condition that additional clinical data is collected, usually through a national registry or clinical trial.
In place of CED, officials could restore the Medicare Coverage of...
Today's Sponsors
Today's Sponsor